Hanley Ramirez Getty

Smart money on Hanley Ramirez, Jay Bruce in prop bets

26 Comments

Bovada released its player prop bets for the 2014 season on Wednesday, providing odds on the AL and NL MVP and Cy Young races, as well as MLB’s home run leader. Here’s a look at what I consider to be the best bets in each category. Please do note, though, all information here is for entertainment purposes only.

AL MVP

Mike Trout – 5/1
Miguel Cabrera – 6/1
Adrian Beltre – 16/1

This is one spot where I’d seriously think about going with the favorites. I’d say it’s better than 50-50 that Trout or Cabrera will claim the award, and the opportunity is there to bet both and still make some cash. Cabrera, of course, has won two in a row.

Since RBI remains king, Beltre, who has tied for the eighth best odds here, has the best chance to upset them. He’s in position to drive in a ton of runs behind Shin-Soo Choo, Elvis Andrus and Prince Fielder in the Texas order.

My favorite sleeper pick doesn’t get listed by Bovada, which probably means he’d get 50:1 odds. That’s Carlos Santana, who is also in position to drive in a whole bunch of runs behind Michael Bourn, Nick Swisher and Jason Kipnis in the Cleveland lineup.

NL MVP

Hanley Ramirez – 25/1
Paul Goldschmidt – 9/1
Jay Bruce – 33/1

Ramirez was the NL’s best hitter in the half-season he was healthy last year, and his Dodgers are the clear favorites in the NL West. I see him making a run at a batting title and hitting about 30 homers. He’s my pick for MVP, long odds or no.

Goldschmidt has the third best odds here behind Andrew McCutchen (6/1) and Joey Votto (7/1). Because, again, RBI is king, I’d say he’s more likely to win than either of those two. However, for it to happen, he’ll need the Diamondbacks to make the postseason.

Bruce is going to have at least one 40-homer, 120-RBI season before he’s done. I doubt he’ll actually be a better player than Votto, but he’s the one of the two more likely to win an MVP, mostly because he gets to hit behind the guy with the .430 OBP.

AL Cy Young

Alex Cobb – 33/1
Justin Verlander – 12/1
Felix Hernandez – 15/1

Bovada and I agree: AL Cy Young is the most wide open of the four major awards. Their top choice here, Yu Darvish, has the highest odds (8/1) of the favorites. I don’t have a real favorite here, either. My projections call for Verlander, Hernandez, Darvish, David Price, Cobb and Chris Sale to all finish with ERAs in the 3.00-3.20 range, with no one lower than that. I’d be tempted to throw a couple of bucks on Cobb, but I’d probably otherwise shy away.

NL Cy Young

Clayton Kershaw – 13/2
Madison Bumgarner – 15/1
Stephen Strasburg – 8/1

I’d go with the favorite here: Kershaw seems like he should be closer to 4:1 to repeat, in my opinion. If he doesn’t pitch up to his ability, that might open the door for Bumgarner. One sleeper pick who didn’t get odds from Bovada: Homer Bailey. He’d be really nice at 50:1 or 66:1.

MLB home run leader

Jay Bruce: 25/1
Chris Davis: 8/1
Giancarlo Stanton: 10/1
Justin Upton: 75/1

I have nine guys projected to hit at least 34 homers this season:

39 – Davis
38 – Stanton
37 – Bruce, Fielder
35 – Jose Bautista, Miguel Cabrera, Mark Trumbo
34 – Pedro Alvarez, Edwin Encarncion

Bovada has Davis as the favorite at 8/1, followed by Cabrera at 9/1 and Stanton at 10/1. So we line up rather closely here. Bruce at 25/1 seems like the best bet to me: very good HR ballpark, very durable, three straight 30-homer seasons. Trumbo at 20/1 isn’t bad, either.

For a long shot, Upton is rather tempting. I have him at 30 homers, but he’s capable of doing better. Last year, he hit 12 in April alone, and he’s just now entering his age-26 season.

Athletics acquire Khris Davis in trade with Brewers

Milwaukee Brewers' Khris Davis swings on a home run during the eighth inning of a baseball game against the San Diego Padres on Tuesday, July 23, 2013, in Milwaukee. (AP Photo/Morry Gash)
AP Photo/Morry Gash
2 Comments

The Brewers’ rebuild continues, as the club announced on Twitter the trade of outfielder Khris Davis to the Athletics in exchange for catcher Jacob Nottingham and pitcher Bubba Derby. MLB.com’s Jane Lee reports that the A’s have designated pitcher Sean Nolin for assignment to create room on the 40-man roster for Davis.

Davis, 28, was the Brewers’ most valuable remaining trade chip. He blasted 27 home runs while hitting .247/.323/.505 in 440 plate appearances this past season in Milwaukee. Adding to his value, Davis won’t become eligible for arbitration until after the 2016 season and can’t become a free agent until after the 2019 season. In Oakland, Davis will give the Athletics more reliability as Coco Crisp was injured for most of last season and is now 36 years old. Though he doesn’t have much of a career platoon split, Davis split time in left field with the left-handed-hitting Gerardo Parra last season. It’s unclear if the A’s will utilize him in a platoon as well.

With Davis out of the picture, Domingo Santana is a leading candidate to start in left field for the Brewers, GM David Stearns said, per Tom Haudricourt of the Milwaukee Journal Sentinel.

Nottingham, 20, started the 2015 season in the Astros’ system but went to the Athletics in the Scott Kazmir deal. He hit an aggregate .316/.372/.505 at Single-A, showing plenty of promise early in his professional career. With catcher Jonathan Lucroy on his way out of Milwaukee, the Brewers are hoping Nottingham can be their next permanent backstop.

Derby, 21, made his professional debut last season after the Athletics drafted him in the sixth round. Across 37 1/3 innings, he yielded seven runs (five earned) on 24 hits and 10 walks with 47 strikeouts. He’s obviously a few years away from the majors, but the Brewers are looking for high upside.

Yankees, Aroldis Chapman avoid arbitration at $11.325 million

Aroldis Chapman
AP Photo/Charles Rex Arbogast
1 Comment

Ken Rosenthal of FOX Sports reports that the Yankees and closer Aroldis Chapman have avoided arbitration, settling on an $11.325 million salary for the 2016 season. It is the lefty’s third and final year of arbitration eligibility.

Chapman had filed for $13 million while the Yankees countered at $9 million, so he gets slightly more than the midpoint between the two submitted figures.

With the Reds this past season, Chapman posted a 1.63 ERA with 33 saves and a 116/33 K/BB ratio over 66 1/3 innings. The Reds have opted to rebuild, so they traded him to the Yankees this offseason in exchange for four minor leaguers. Chapman, who turns 28 at the end of February, will make for a fearsome 1-2-3 punch in the back of the Yankees’ bullpen along with Andrew Miller and Dellin Betances.

Indians sign reliever Tommy Hunter to $2 million deal

Baltimore Orioles relief pitcher Tommy Hunter throws to the Miami Marlins during the seventh inning of a baseball game in Miami, Friday, May 22, 2015. (AP Photo/J Pat Carter)
Leave a comment

Paul Hoynes of the Cleveland Plain Dealer reports that right-hander Tommy Hunter has agreed to a one-year, $2 million contract with the Indians. It’s a major-league deal, so Hunter gets a spot on the 40-man roster and will be in the Opening Day bullpen if he’s fully recovered from core muscle surgery.

Hunter split last season between the Orioles and Cubs, totaling 60 innings with a 4.18 ERA and 47/14 K/BB ratio. He had a sub-3.00 ERA in both 2013 and 2014, and has generally been a setup-caliber reliever since shifting to the bullpen full time.

He has good control and a mid-90s fastball, but Hunter has never missed many bats despite the big-time velocity and often struggles to keep the ball in the ballpark. He’ll likely fill a middle relief role in Cleveland initially.

“YER OUT!” Jenrry Mejia permanently suspended for a third positive PED test

Jenrry Mejia
25 Comments

You knew someone would be dumb enough to do this eventually, you just didn’t know who. Now we do: MLB just announced that reliever Jenrry Mejia has been permanently suspended after testing positive for Boldenone. That was his third positive test and under the Joint Drug Agreement that means his career is more or less over.

Mejia’s three strikes came in pretty rapid succession. On April 11, 2015 it was announced that Mejía had been suspended for 80 games after testing positive for use of stanozolol. On July 28, 2015 it was announced that Mejia had failed a test for Stanozolol again and Boldenone to boot, giving him a 162-game suspension, which he’d still be serving at the beggining of the season. Now this third test.

Mejia has played five seasons in the big. He started with so much promise, looking like a great prospect coming up. His performance only matched the promise in fits and starts, however, resulting in a 9-14 record with a 3.68 ERA and a K/BB ratio of 162/76 in 183.1 innings, all with the Mets.

Per the rules of the Joint Drug Agreement, Mejia can apply for reinstatement after being banned for two years. But it would obviously require him to spend two years doing a lot of smart things he hasn’t been doing in the past year. And it would also represent a near-unprecedented comeback. It could happen, I suppose, but it’s a far safer bet that his career is over.